Galanan, Lelebeth L.

HRN: 14-89-80  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2022
CEFUROXIME 1.5GM (VIAL)
08/15/2022
08/21/2022
IV
1.5g
Q8hours
UTI
08/15/2022
CEFUROXIME 1.5GM (VIAL)
08/15/2022
08/22/2022
IVT
1.5g
Q8
S/P LTCS
Waiting Final Action 
08/16/2022
CEFUROXIME 500MG (TAB)
08/16/2022
08/22/2022
ORAL
500mg
BID
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: